Top Markets
Coin of the day
Vaxil Bio Ltd. Vaxil Bio Ltd.

Vaxil Bio Ltd.

VXL
Peringkat dalam Saham #39496
Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing... Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing innovative therapeutic agents. Its foundation lies in a unique signal peptide-based platform, which it leverages to address critical health challenges, specifically infectious diseases and various cancers. The company's primary therapeutic candidate, ImMucin, has successfully advanced through Phase I/II clinical trials as a potential treatment for multiple myeloma. Beyond ImMucin, Vaxil Bio is actively developing a vaccine/treatment for tuberculosis, as well as a vaccine targeting coronavirus (COVID-19). Strategic alliances bolster its research efforts; Vaxil Bio collaborates with The Tel Aviv Sourasky Medical Center on a research initiative to create a peptide-based COVID-19 vaccine. Furthermore, it holds a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Infectious Diseases to assess CorVax's efficacy in preventing COVID-19 in murine models. Established in 2006, the company's operations are based in Toronto, Canada.
Harga Saham
$0.1174299
Terakhir disinkronkan: 2026-08-13
Kapitalisasi Pasar
$467.84K
Perubahan (1 hari)
-8.57%
Perubahan (1 tahun)
1.38%
Negara
CA
Perdagangan Vaxil Bio Ltd. (VXL)

Kategori

Riwayat harga saham Vaxil Bio Ltd. (VXL)
Harga penutupan tertinggi: $0.13 pada 2026-08-01

Harga penutupan terendah: $137.64 pada 2010-03-01
Riwayat harga saham Vaxil Bio Ltd. dari 2010 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 24.66%
2025 -72.61%
2024 -24.06%
2023 -28.26%
2022 -76.68%
2021 -41.79%
2020 258.87%
2019 16.10%
2018 -52.29%
2017 -41.76%
2016 16.83%
2015 -19.78%
2014 -67.07%
2013 -46.95%
2012 -44.33%
2011 -48.81%
2010 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$517.18 32.51%
US
$857.76 31.47%
NL
$734.30 7.51%
CH
$1.07K -6.40%
KR
$258.11 14.02%
BE